- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 8.00 Å
- Oligo State
- hetero-6-6-6-6-6-mer
- Ligands
- 6 x LEU- ILE- GLY- ARG- THR: human coxsackievirus A21(Non-covalent)
- 48 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
NAG.2: 3 residues within 4Å:- Chain E: N.103, T.145, L.147
Ligand excluded by PLIPNAG.3: 4 residues within 4Å:- Chain E: A.117, N.118, P.167, Q.168
Ligand excluded by PLIPNAG.4: 3 residues within 4Å:- Chain E: G.126, E.127, N.156
Ligand excluded by PLIPNAG.5: 7 residues within 4Å:- Chain E: T.85, P.86, E.87, F.173, E.174, N.175
- Ligands: NAG.6
Ligand excluded by PLIPNAG.6: 4 residues within 4Å:- Chain E: Y.83, W.84, T.85
- Ligands: NAG.5
Ligand excluded by PLIPNAG.7: 2 residues within 4Å:- Chain E: G.239, N.240
Ligand excluded by PLIPNAG.8: 3 residues within 4Å:- Chain E: W.97, P.99, N.269
Ligand excluded by PLIPNAG.9: 1 residues within 4Å:- Chain E: N.358
Ligand excluded by PLIPNAG.11: 3 residues within 4Å:- Chain J: N.103, T.145, L.147
Ligand excluded by PLIPNAG.12: 4 residues within 4Å:- Chain J: A.117, N.118, P.167, Q.168
Ligand excluded by PLIPNAG.13: 3 residues within 4Å:- Chain J: G.126, E.127, N.156
Ligand excluded by PLIPNAG.14: 7 residues within 4Å:- Chain J: T.85, P.86, E.87, F.173, E.174, N.175
- Ligands: NAG.15
Ligand excluded by PLIPNAG.15: 4 residues within 4Å:- Chain J: Y.83, W.84, T.85
- Ligands: NAG.14
Ligand excluded by PLIPNAG.16: 2 residues within 4Å:- Chain J: G.239, N.240
Ligand excluded by PLIPNAG.17: 3 residues within 4Å:- Chain J: W.97, P.99, N.269
Ligand excluded by PLIPNAG.18: 1 residues within 4Å:- Chain J: N.358
Ligand excluded by PLIPNAG.20: 3 residues within 4Å:- Chain O: N.103, T.145, L.147
Ligand excluded by PLIPNAG.21: 4 residues within 4Å:- Chain O: A.117, N.118, P.167, Q.168
Ligand excluded by PLIPNAG.22: 3 residues within 4Å:- Chain O: G.126, E.127, N.156
Ligand excluded by PLIPNAG.23: 7 residues within 4Å:- Chain O: T.85, P.86, E.87, F.173, E.174, N.175
- Ligands: NAG.24
Ligand excluded by PLIPNAG.24: 4 residues within 4Å:- Chain O: Y.83, W.84, T.85
- Ligands: NAG.23
Ligand excluded by PLIPNAG.25: 2 residues within 4Å:- Chain O: G.239, N.240
Ligand excluded by PLIPNAG.26: 3 residues within 4Å:- Chain O: W.97, P.99, N.269
Ligand excluded by PLIPNAG.27: 1 residues within 4Å:- Chain O: N.358
Ligand excluded by PLIPNAG.29: 3 residues within 4Å:- Chain T: N.103, T.145, L.147
Ligand excluded by PLIPNAG.30: 4 residues within 4Å:- Chain T: A.117, N.118, P.167, Q.168
Ligand excluded by PLIPNAG.31: 3 residues within 4Å:- Chain T: G.126, E.127, N.156
Ligand excluded by PLIPNAG.32: 7 residues within 4Å:- Chain T: T.85, P.86, E.87, F.173, E.174, N.175
- Ligands: NAG.33
Ligand excluded by PLIPNAG.33: 4 residues within 4Å:- Chain T: Y.83, W.84, T.85
- Ligands: NAG.32
Ligand excluded by PLIPNAG.34: 2 residues within 4Å:- Chain T: G.239, N.240
Ligand excluded by PLIPNAG.35: 3 residues within 4Å:- Chain T: W.97, P.99, N.269
Ligand excluded by PLIPNAG.36: 1 residues within 4Å:- Chain T: N.358
Ligand excluded by PLIPNAG.38: 3 residues within 4Å:- Chain Y: N.103, T.145, L.147
Ligand excluded by PLIPNAG.39: 4 residues within 4Å:- Chain Y: A.117, N.118, P.167, Q.168
Ligand excluded by PLIPNAG.40: 3 residues within 4Å:- Chain Y: G.126, E.127, N.156
Ligand excluded by PLIPNAG.41: 7 residues within 4Å:- Chain Y: T.85, P.86, E.87, F.173, E.174, N.175
- Ligands: NAG.42
Ligand excluded by PLIPNAG.42: 4 residues within 4Å:- Chain Y: Y.83, W.84, T.85
- Ligands: NAG.41
Ligand excluded by PLIPNAG.43: 2 residues within 4Å:- Chain Y: G.239, N.240
Ligand excluded by PLIPNAG.44: 3 residues within 4Å:- Chain Y: W.97, P.99, N.269
Ligand excluded by PLIPNAG.45: 1 residues within 4Å:- Chain Y: N.358
Ligand excluded by PLIPNAG.47: 3 residues within 4Å:- Chain 3: N.103, T.145, L.147
Ligand excluded by PLIPNAG.48: 4 residues within 4Å:- Chain 3: A.117, N.118, P.167, Q.168
Ligand excluded by PLIPNAG.49: 3 residues within 4Å:- Chain 3: G.126, E.127, N.156
Ligand excluded by PLIPNAG.50: 7 residues within 4Å:- Chain 3: T.85, P.86, E.87, F.173, E.174, N.175
- Ligands: NAG.51
Ligand excluded by PLIPNAG.51: 4 residues within 4Å:- Chain 3: Y.83, W.84, T.85
- Ligands: NAG.50
Ligand excluded by PLIPNAG.52: 2 residues within 4Å:- Chain 3: G.239, N.240
Ligand excluded by PLIPNAG.53: 3 residues within 4Å:- Chain 3: W.97, P.99, N.269
Ligand excluded by PLIPNAG.54: 1 residues within 4Å:- Chain 3: N.358
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Xiao, C. et al., The crystal structure of coxsackievirus a21 and its interaction with icam-1. Structure (2005)
- Release Date
- 2005-08-02
- Peptides
- human coxsackievirus A21: AFKPUZ
human coxsackievirus A21: BGLQV0
human coxsackievirus A21: CHMRW1
human coxsackievirus A21: DINSX2
Intercellular adhesion molecule-1: EJOTY3 - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
1F
1K
1P
1U
1Z
1B
2G
2L
2Q
2V
20
2C
3H
3M
3R
3W
31
3D
4I
4N
4S
4X
42
4E
IJ
IO
IT
IY
I3
I
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 8.00 Å
- Oligo State
- hetero-6-6-6-6-6-mer
- Ligands
- 6 x LEU- ILE- GLY- ARG- THR: human coxsackievirus A21(Non-covalent)
- 48 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Xiao, C. et al., The crystal structure of coxsackievirus a21 and its interaction with icam-1. Structure (2005)
- Release Date
- 2005-08-02
- Peptides
- human coxsackievirus A21: AFKPUZ
human coxsackievirus A21: BGLQV0
human coxsackievirus A21: CHMRW1
human coxsackievirus A21: DINSX2
Intercellular adhesion molecule-1: EJOTY3 - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
1F
1K
1P
1U
1Z
1B
2G
2L
2Q
2V
20
2C
3H
3M
3R
3W
31
3D
4I
4N
4S
4X
42
4E
IJ
IO
IT
IY
I3
I